News
One-time Amtagvi Treatment Demonstrated Durable Responses and a Five-year Overall Survival Rate of 20%. Five-year Follow Up is Unprecedented for Any Therapy in Patients with Advan ...
One-time Amtagvi Treatment Demonstrated Durable Responses and a Five-year Overall Survival Rate of 20% Five-year Follow Up is Unprecedented for Any Therapy in Patients with Advanced Melanoma Previousl ...
An Oklahoma City doctor paid$130,000 to settle civil penalty claims stemming from allegations that he failed to maintain DEA ...
Kid Cudi shared a message thanking his fans for their support after testifying in Sean "Diddy" Combs federal sex trafficking ...
EMD Serono, the Healthcare business of Merck KGaA, Darmstadt, Germany, in the U.S. and Canada, today announced the presentation of new oncology data across more than 12 tumor types at the 2025 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results